Oxidative stress may suppress cancer onset in individuals with BRCA2 gene variants
Peer-Reviewed Publication
Updates every hour. Last Updated: 14-Aug-2025 17:11 ET (14-Aug-2025 21:11 GMT/UTC)
Recently, a collaborative research team led by Professor Yong-Qiang Li of Shandong University and Professor Yanmei Yang of Shandong Normal University systematically investigated the physical binding mechanisms between enzymes and the photosensitizer chlorin e6 (Ce6), and proposed a catalytically enhanced strategy for photodynamic therapy (PDT). The study demonstrated that the extent of positively charged regions on the enzyme surface could be served as a reliable indicator for evaluating and predicting the enzyme’s binding affinity to Ce6. Based on this criterion, the authors further developed catalase-Ce6 nanoconjugates (CAT-Ce6 NCs) exhibiting excellent stability and potent photodynamic antibacterial activity. The CAT-Ce6 NCs effectively remodeled hypoxic pathological microenvironments and eradicated bacteria, thereby promoting the advancement of catalysis-augmented PDT of bacterial infections. The aforementioned study, titled "Deciphering the Physical Binding Mechanism of Enzyme–Photosensitizer Facilitates Catalysis-Augmented Photodynamic Therapy," was published in the journal Research.
A new study from the University of Colorado Anschutz Medical Campus shows that free, open-source artificial intelligence (AI) tools can help doctors report medical scans just as well as more expensive commercial systems without putting patient privacy at risk.
A major new study led by the University of Sydney suggests that walking 7000 steps a day offers similar health benefits across several outcomes as walking 10,000.
A new study has found that the bone fracture protection women get from menopausal hormone therapy (MHT, also known as HRT) disappears within a year of stopping treatment.
In the new study, published in Lancet Healthy Longevity, experts from the School of Medicine at the University of Nottingham, also found that in most cases, stopping treatment is then followed by some years of elevated fracture risk compared to women who have never used MHT. Fracture risks then falls to be similar to, and then lower than women who have never used MHT.
The study was funded by the National Institute for Health and Care Research (NIHR) SPCR.